IBA FY21 Trading Update
PROFITABILITY ACROSS ALL BUSINESS LINES
Louvain-la-Neuve, Belgium, 1 February
2022 - IBA (Ion Beam Applications SA), the world leader in
particle accelerator technology, today provides a trading update
ahead of the Company’s full-year results on 24 March 2022.
IBA will report FY21 Group sales in line with
the prior year, with a positive REBIT and net profit at Group level
and profitability across all business lines.
- High order intake across all business lines
- Proton Therapy saw a continued revival in activity with five
systems (nine rooms) sold in Asia, Europe and the US, compared with
two systems sold in the prior year
- Other Accelerators had another excellent year with more than 30
systems sold, up from 17 systems last year
- The Dosimetry business has continued to perform well with order
intake in line with the prior year
- Equipment and Services backlog at a new all-time high of EUR
1.2 billion
- Highly active pipeline, particularly in the US and Asia, with
continuing momentum providing significant visibility for 2022 and
beyond
- All time high net cash position of EUR 130.3 million
(unaudited) at year end, providing the business a solid foundation
to progress its strategic objectives
Olivier Legrain, Chief Executive Officer
of IBA, commented: “IBA performed
exceptionally well in 2021, with a high order intake and
profitability demonstrated across all business lines. IBA’s market
leading product offerings in proton therapy, other accelerators,
radiopharmaceuticals and dosimetry have driven this momentum, which
continued to build throughout the year. We have entered 2022 in a
strong position with an active global pipeline for all businesses,
particularly in the US and Asia. Our record high cash position
provides us with a solid foundation from which we can explore other
growth areas such as theranostics, whilst achieving our goal of
long-term sustainable profitability.”
IBA will publish its consolidated results for
the full year 2021 on Thursday, 24 March 2022 at 7am CET.
In addition to the press release, Olivier
Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief
Financial Officer, will host a conference call and webcast,
conducted in English, to present the 2021 full year results,
followed by a Q&A session.
Conference Call InformationThis
conference call will be held on Thursday, 24 March 2022 at 3pm CET
/ 2pm GMT / 10am EDT / 7am PDT as a Teams webinar and can be
accessed online on this link.If you would like to join by phone
only, please dial (Phone conference ID 913 259 995#):
Belgium:
+32 2 890 97
20UK:
+44 20 3321
5200NL:
+31 20 708
6901LU:
+352 27 87 00
02US:
+1
347-991-7591FR:
+33 1 70 99 53 51
The presentation will be available on IBA’s
investor relations website and
on:https://www.iba-worldwide.com/content/iba-full-year-2021-results-press-release-and-web-conference
shortly before the call.
To ensure a timely connection, it is recommended
that users register at least 10 minutes prior to the scheduled
webcast.
For participants who do not have the Teams
application installed, please follow the process described in this
link to access the conference.
Shareholder’s AgendaFull Year
Results
24 March 2022Business Update First Quarter
2022
19 May 2022General
Assembly
8 June 2022Half Year 2022
Results
31 August 2022Business Update Third Quarter
2022
17 November 2022
***Ends***
About IBAIBA (Ion Beam
Applications S.A.) is the world leader in particle accelerator
technology. The company is the leading supplier of equipment and
services in the field of proton therapy, considered to be the most
advanced form of radiation therapy available today. IBA is also a
leading player in the fields of industrial sterilization,
radiopharmaceuticals and dosimetry. The company, based in
Louvain-la-Neuve, Belgium, employs approximately 1,500 people
worldwide. IBA is a certified B Corporation (B Corp) meeting the
highest standards of verified social and environmental
performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
CONTACTS
Soumya
ChandramouliChief Financial Officer+32 10
475 890Investorrelations@iba-group.com
Olivier LechienCorporate
Communication Director+32 10 475 890communication@iba-group.com
Consilium Strategic
CommunicationsAmber Fennell, Angela Gray, Lucy
Featherstone+44 (0) 20 3709 5700IBA@consilium-comms.com
- 220201-IBA_2021_Trading_Update-EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024